Content area

|
|

Betablokkere kan gavne patienter med KOL og hjertesygdom

Forfatter(e)
Daniel Bech Rasmussen1, Peter Lange2, 3 & Magnus Thorsten Jensen1 1) Medicinsk Afdeling, Holbæk Sygehus 2) Afdeling for Social Medicin, Institut for Folkesundhedsvidenskab, Københavns Universitet 3) Lungemedicinsk Sektion, Hvidovre Hospital Ugeskr Læger 2015;177:V02150184
Reference: 
Ugeskr Læger 2015;177:V02150184
Blad nummer: 
Sidetal: 
2-5
Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment
Chronic obstructive pulmonary disease (COPD) and coronary heart disease share smoking as the most important com­mon risk factor and there is a high prevalence of cardio­vascular disease among COPD patients. Although cardiose­lective beta-blockers are safe in treatment of COPD, they are often withheld in these patients. In observational studies, beta-blocker treatment is associated with significantly reduced mortality and reduced risk of exacerbations of COPD. This effect may be caused by the beneficial effect of beta-blockers on heart failure, tachycardia and upregulation of beta-receptors in the airways.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Marianne Puge Nielsen | 13/11
1 Kommentar
af Akil Raad Kami Abdel-Wahab Walli | 13/11
6 kommentarer
af Larry Højgaard Kristiansen | 11/11
1 Kommentar
af Sven Refslund Poulsen | 09/11
3 kommentarer
af Christian Crüger | 06/11
1 Kommentar
af Anders Christiansen | 05/11
1 Kommentar
af Thamilini Umaramanan | 05/11
2 kommentarer